APO Research
Talk to an analyst

APO RESEARCH · REPORT

Steroid APIs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Steroid APIs Market Analysis and Forecast 2026-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchSteroid APIs Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Steroid APIs Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Steroid APIs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Steroid APIs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Steroid APIs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Steroid APIs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Steroid APIs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Steroid APIs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Steroid APIs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Steroid APIs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Steroid APIs include Zhejiang Xianju Pharmaceutical, Tianjin Tianyao Pharmaceutical, Sanofi, MSD, Tianjin Jinjin Pharmaceutical, Pfizer, Henan LIHUA Pharmaceutical, Bayer and Steroid, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Steroid APIs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Steroid APIs, also provides the sales of main regions and countries. Of the upcoming market potential for Steroid APIs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Steroid APIs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Steroid APIs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Steroid APIs sales, projected growth trends, production technology, application and end-user industry.

Steroid APIs Segment by Company

Zhejiang Xianju Pharmaceutical

Tianjin Tianyao Pharmaceutical

Sanofi

MSD

Tianjin Jinjin Pharmaceutical

Pfizer

Henan LIHUA Pharmaceutical

Bayer

Steroid

Steroid APIs Segment by Type

Estrogens

Anabolics

Corticosteroids

Progestinics

Others

Steroid APIs Segment by Application

Industrial

Laboratory

Steroid APIs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Steroid APIs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Steroid APIs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Steroid APIs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Steroid APIs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Steroid APIs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Steroid APIs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Steroid APIs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Estrogens Major Manufacturers Table 3. Anabolics Major Manufacturers Table 4. Corticosteroids Major Manufacturers Table 5. Progestinics Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Steroid APIs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Industrial Major Manufacturers Table 9. Laboratory Major Manufacturers Table 10. Steroid APIs Industry Trends Table 11. Steroid APIs Industry Drivers Table 12. Steroid APIs Industry Opportunities and Challenges Table 13. Steroid APIs Industry Restraints Table 14. Global Steroid APIs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Steroid APIs Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Steroid APIs Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Steroid APIs Revenue Market Share by Region (2021-2026) Table 18. Global Steroid APIs Revenue Market Share by Region (2027-2032) Table 19. Global Steroid APIs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (tons) Table 20. Global Steroid APIs Sales by Region (2021-2026) & (tons) Table 21. Global Steroid APIs Sales by Region (2027-2032) & (tons) Table 22. Global Steroid APIs Sales Market Share by Region (2021-2026) Table 23. Global Steroid APIs Sales Market Share by Region (2027-2032) Table 24. Global Steroid APIs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Steroid APIs Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Steroid APIs Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Steroid APIs Sales Market Share by Manufacturers (2021-2026) Table 28. Global Steroid APIs Sales Price (US$/ton) of Manufacturers (2021-2026) Table 29. Global Steroid APIs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Steroid APIs Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Steroid APIs Manufacturers, Product Type & Application Table 32. Global Steroid APIs Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Steroid APIs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Steroid APIs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Steroid APIs Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Steroid APIs Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Steroid APIs Revenue Market Share by Type (2021-2026) Table 39. Global Steroid APIs Revenue Market Share by Type (2027-2032) Table 40. Global Steroid APIs Sales by Type 2021 VS 2025 VS 2032 (tons) Table 41. Global Steroid APIs Sales by Type (2021-2026) & (tons) Table 42. Global Steroid APIs Sales by Type (2027-2032) & (tons) Table 43. Global Steroid APIs Sales Market Share by Type (2021-2026) Table 44. Global Steroid APIs Sales Market Share by Type (2027-2032) Table 45. Global Steroid APIs Price by Type (2021-2026) & (US$/ton) Table 46. Global Steroid APIs Price by Type (2027-2032) & (US$/ton) Table 47. Global Steroid APIs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Steroid APIs Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Steroid APIs Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Steroid APIs Revenue Market Share by Application (2021-2026) Table 51. Global Steroid APIs Revenue Market Share by Application (2027-2032) Table 52. Global Steroid APIs Sales by Application 2021 VS 2025 VS 2032 (tons) Table 53. Global Steroid APIs Sales by Application (2021-2026) & (tons) Table 54. Global Steroid APIs Sales by Application (2027-2032) & (tons) Table 55. Global Steroid APIs Sales Market Share by Application (2021-2026) Table 56. Global Steroid APIs Sales Market Share by Application (2027-2032) Table 57. Global Steroid APIs Price by Application (2021-2026) & (US$/ton) Table 58. Global Steroid APIs Price by Application (2027-2032) & (US$/ton) Table 59. Zhejiang Xianju Pharmaceutical Company Information Table 60. Zhejiang Xianju Pharmaceutical Business Overview Table 61. Zhejiang Xianju Pharmaceutical Steroid APIs Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 62. Zhejiang Xianju Pharmaceutical Steroid APIs Product Portfolio Table 63. Zhejiang Xianju Pharmaceutical Recent Development Table 64. Tianjin Tianyao Pharmaceutical Company Information Table 65. Tianjin Tianyao Pharmaceutical Business Overview Table 66. Tianjin Tianyao Pharmaceutical Steroid APIs Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 67. Tianjin Tianyao Pharmaceutical Steroid APIs Product Portfolio Table 68. Tianjin Tianyao Pharmaceutical Recent Development Table 69. Sanofi Company Information Table 70. Sanofi Business Overview Table 71. Sanofi Steroid APIs Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 72. Sanofi Steroid APIs Product Portfolio Table 73. Sanofi Recent Development Table 74. MSD Company Information Table 75. MSD Business Overview Table 76. MSD Steroid APIs Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 77. MSD Steroid APIs Product Portfolio Table 78. MSD Recent Development Table 79. Tianjin Jinjin Pharmaceutical Company Information Table 80. Tianjin Jinjin Pharmaceutical Business Overview Table 81. Tianjin Jinjin Pharmaceutical Steroid APIs Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 82. Tianjin Jinjin Pharmaceutical Steroid APIs Product Portfolio Table 83. Tianjin Jinjin Pharmaceutical Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Steroid APIs Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 87. Pfizer Steroid APIs Product Portfolio Table 88. Pfizer Recent Development Table 89. Henan LIHUA Pharmaceutical Company Information Table 90. Henan LIHUA Pharmaceutical Business Overview Table 91. Henan LIHUA Pharmaceutical Steroid APIs Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 92. Henan LIHUA Pharmaceutical Steroid APIs Product Portfolio Table 93. Henan LIHUA Pharmaceutical Recent Development Table 94. Bayer Company Information Table 95. Bayer Business Overview Table 96. Bayer Steroid APIs Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 97. Bayer Steroid APIs Product Portfolio Table 98. Bayer Recent Development Table 99. Steroid Company Information Table 100. Steroid Business Overview Table 101. Steroid Steroid APIs Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 102. Steroid Steroid APIs Product Portfolio Table 103. Steroid Recent Development Table 104. North America Steroid APIs Revenue by Type (2021-2026) & (US$ Million) Table 105. North America Steroid APIs Revenue by Type (2027-2032) & (US$ Million) Table 106. North America Steroid APIs Sales by Type (2021-2026) & (tons) Table 107. North America Steroid APIs Sales by Type (2027-2032) & (tons) Table 108. North America Steroid APIs Sales Price by Type (2021-2026) & (US$/ton) Table 109. North America Steroid APIs Sales Price by Type (2027-2032) & (US$/ton) Table 110. North America Steroid APIs Revenue by Application (2021-2026) & (US$ Million) Table 111. North America Steroid APIs Revenue by Application (2027-2032) & (US$ Million) Table 112. North America Steroid APIs Sales by Application (2021-2026) & (tons) Table 113. North America Steroid APIs Sales by Application (2027-2032) & (tons) Table 114. North America Steroid APIs Sales Price by Application (2021-2026) & (US$/ton) Table 115. North America Steroid APIs Sales Price by Application (2027-2032) & (US$/ton) Table 116. North America Steroid APIs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Steroid APIs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. North America Steroid APIs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. North America Steroid APIs Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 120. North America Steroid APIs Sales by Country (2021-2026) & (tons) Table 121. North America Steroid APIs Sales by Country (2027-2032) & (tons) Table 122. North America Steroid APIs Sales Price by Country (2021-2026) & (US$/ton) Table 123. North America Steroid APIs Sales Price by Country (2027-2032) & (US$/ton) Table 124. United States Steroid APIs Revenue (2021-2032) & (US$ Million) Table 125. Canada Steroid APIs Revenue (2021-2032) & (US$ Million) Table 126. Mexico Steroid APIs Revenue (2021-2032) & (US$ Million) Table 127. Europe Steroid APIs Revenue by Type (2021-2026) & (US$ Million) Table 128. Europe Steroid APIs Revenue by Type (2027-2032) & (US$ Million) Table 129. Europe Steroid APIs Sales by Type (2021-2026) & (tons) Table 130. Europe Steroid APIs Sales by Type (2027-2032) & (tons) Table 131. Europe Steroid APIs Sales Price by Type (2021-2026) & (US$/ton) Table 132. Europe Steroid APIs Sales Price by Type (2027-2032) & (US$/ton) Table 133. Europe Steroid APIs Revenue by Application (2021-2026) & (US$ Million) Table 134. Europe Steroid APIs Revenue by Application (2027-2032) & (US$ Million) Table 135. Europe Steroid APIs Sales by Application (2021-2026) & (tons) Table 136. Europe Steroid APIs Sales by Application (2027-2032) & (tons) Table 137. Europe Steroid APIs Sales Price by Application (2021-2026) & (US$/ton) Table 138. Europe Steroid APIs Sales Price by Application (2027-2032) & (US$/ton) Table 139. Europe Steroid APIs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Europe Steroid APIs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. Europe Steroid APIs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. Europe Steroid APIs Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 143. Europe Steroid APIs Sales by Country (2021-2026) & (tons) Table 144. Europe Steroid APIs Sales by Country (2027-2032) & (tons) Table 145. Europe Steroid APIs Sales Price by Country (2021-2026) & (US$/ton) Table 146. Europe Steroid APIs Sales Price by Country (2027-2032) & (US$/ton) Table 147. Germany Steroid APIs Revenue (2021-2032) & (US$ Million) Table 148. France Steroid APIs Revenue (2021-2032) & (US$ Million) Table 149. U.K. Steroid APIs Revenue (2021-2032) & (US$ Million) Table 150. Italy Steroid APIs Revenue (2021-2032) & (US$ Million) Table 151. Russia Steroid APIs Revenue (2021-2032) & (US$ Million) Table 152. Spain Steroid APIs Revenue (2021-2032) & (US$ Million) Table 153. Netherlands Steroid APIs Revenue (2021-2032) & (US$ Million) Table 154. Switzerland Steroid APIs Revenue (2021-2032) & (US$ Million) Table 155. Sweden Steroid APIs Revenue (2021-2032) & (US$ Million) Table 156. Poland Steroid APIs Revenue (2021-2032) & (US$ Million) Table 157. China Steroid APIs Revenue by Type (2021-2026) & (US$ Million) Table 158. China Steroid APIs Revenue by Type (2027-2032) & (US$ Million) Table 159. China Steroid APIs Sales by Type (2021-2026) & (tons) Table 160. China Steroid APIs Sales by Type (2027-2032) & (tons) Table 161. China Steroid APIs Sales Price by Type (2021-2026) & (US$/ton) Table 162. China Steroid APIs Sales Price by Type (2027-2032) & (US$/ton) Table 163. China Steroid APIs Revenue by Application (2021-2026) & (US$ Million) Table 164. China Steroid APIs Revenue by Application (2027-2032) & (US$ Million) Table 165. China Steroid APIs Sales by Application (2021-2026) & (tons) Table 166. China Steroid APIs Sales by Application (2027-2032) & (tons) Table 167. China Steroid APIs Sales Price by Application (2021-2026) & (US$/ton) Table 168. China Steroid APIs Sales Price by Application (2027-2032) & (US$/ton) Table 169. Asia Steroid APIs Revenue by Type (2021-2026) & (US$ Million) Table 170. Asia Steroid APIs Revenue by Type (2027-2032) & (US$ Million) Table 171. Asia Steroid APIs Sales by Type (2021-2026) & (tons) Table 172. Asia Steroid APIs Sales by Type (2027-2032) & (tons) Table 173. Asia Steroid APIs Sales Price by Type (2021-2026) & (US$/ton) Table 174. Asia Steroid APIs Sales Price by Type (2027-2032) & (US$/ton) Table 175. Asia Steroid APIs Revenue by Application (2021-2026) & (US$ Million) Table 176. Asia Steroid APIs Revenue by Application (2027-2032) & (US$ Million) Table 177. Asia Steroid APIs Sales by Application (2021-2026) & (tons) Table 178. Asia Steroid APIs Sales by Application (2027-2032) & (tons) Table 179. Asia Steroid APIs Sales Price by Application (2021-2026) & (US$/ton) Table 180. Asia Steroid APIs Sales Price by Application (2027-2032) & (US$/ton) Table 181. Asia Steroid APIs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. Asia Steroid APIs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. Asia Steroid APIs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. Asia Steroid APIs Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 185. Asia Steroid APIs Sales by Country (2021-2026) & (tons) Table 186. Asia Steroid APIs Sales by Country (2027-2032) & (tons) Table 187. Asia Steroid APIs Sales Price by Country (2021-2026) & (US$/ton) Table 188. Asia Steroid APIs Sales Price by Country (2027-2032) & (US$/ton) Table 189. Japan Steroid APIs Revenue (2021-2032) & (US$ Million) Table 190. South Korea Steroid APIs Revenue (2021-2032) & (US$ Million) Table 191. India Steroid APIs Revenue (2021-2032) & (US$ Million) Table 192. Australia Steroid APIs Revenue (2021-2032) & (US$ Million) Table 193. Taiwan Steroid APIs Revenue (2021-2032) & (US$ Million) Table 194. Southeast Asia Steroid APIs Revenue (2021-2032) & (US$ Million) Table 195. SAMEA Steroid APIs Revenue by Type (2021-2026) & (US$ Million) Table 196. SAMEA Steroid APIs Revenue by Type (2027-2032) & (US$ Million) Table 197. SAMEA Steroid APIs Sales by Type (2021-2026) & (tons) Table 198. SAMEA Steroid APIs Sales by Type (2027-2032) & (tons) Table 199. SAMEA Steroid APIs Sales Price by Type (2021-2026) & (US$/ton) Table 200. SAMEA Steroid APIs Sales Price by Type (2027-2032) & (US$/ton) Table 201. SAMEA Steroid APIs Revenue by Application (2021-2026) & (US$ Million) Table 202. SAMEA Steroid APIs Revenue by Application (2027-2032) & (US$ Million) Table 203. SAMEA Steroid APIs Sales by Application (2021-2026) & (tons) Table 204. SAMEA Steroid APIs Sales by Application (2027-2032) & (tons) Table 205. SAMEA Steroid APIs Sales Price by Application (2021-2026) & (US$/ton) Table 206. SAMEA Steroid APIs Sales Price by Application (2027-2032) & (US$/ton) Table 207. SAMEA Steroid APIs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 208. SAMEA Steroid APIs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 209. SAMEA Steroid APIs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 210. SAMEA Steroid APIs Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 211. SAMEA Steroid APIs Sales by Country (2021-2026) & (tons) Table 212. SAMEA Steroid APIs Sales by Country (2027-2032) & (tons) Table 213. SAMEA Steroid APIs Sales Price by Country (2021-2026) & (US$/ton) Table 214. SAMEA Steroid APIs Sales Price by Country (2027-2032) & (US$/ton) Table 215. Brazil Steroid APIs Revenue (2021-2032) & (US$ Million) Table 216. Argentina Steroid APIs Revenue (2021-2032) & (US$ Million) Table 217. Chile Steroid APIs Revenue (2021-2032) & (US$ Million) Table 218. Colombia Steroid APIs Revenue (2021-2032) & (US$ Million) Table 219. Peru Steroid APIs Revenue (2021-2032) & (US$ Million) Table 220. Saudi Arabia Steroid APIs Revenue (2021-2032) & (US$ Million) Table 221. Israel Steroid APIs Revenue (2021-2032) & (US$ Million) Table 222. UAE Steroid APIs Revenue (2021-2032) & (US$ Million) Table 223. Turkey Steroid APIs Revenue (2021-2032) & (US$ Million) Table 224. Iran Steroid APIs Revenue (2021-2032) & (US$ Million) Table 225. Egypt Steroid APIs Revenue (2021-2032) & (US$ Million) Table 226. Key Raw Materials Table 227. Raw Materials Key Suppliers Table 228. Steroid APIs Distributors List Table 229. Steroid APIs Customers List Table 230. Research Programs/Design for This Report Table 231. Authors List of This Report Table 232. Secondary Sources Table 233. Primary Sources List of Figures Figure 1. Steroid APIs Image Figure 2. Global Steroid APIs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Steroid APIs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Estrogens Image Figure 5. Anabolics Image Figure 6. Corticosteroids Image Figure 7. Progestinics Image Figure 8. Others Image Figure 9. Global Steroid APIs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Steroid APIs Market Size Share 2021 VS 2025 VS 2032 Figure 11. Industrial Image Figure 12. Laboratory Image Figure 13. Global Steroid APIs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Steroid APIs Revenue (2021-2032) & (US$ Million) Figure 15. Global Steroid APIs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Steroid APIs Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Steroid APIs Revenue Market Share by Region (2021-2032) Figure 18. Global Steroid APIs Sales (2021-2032) & (tons) Figure 19. Global Steroid APIs Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 20. Global Steroid APIs Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Steroid APIs Sales YoY (2021-2032) & (tons) Figure 22. Europe Steroid APIs Sales YoY (2021-2032) & (tons) Figure 23. China Steroid APIs Sales YoY (2021-2032) & (tons) Figure 24. Asia (Excluding China) Steroid APIs Sales YoY (2021-2032) & (tons) Figure 25. South America, Middle East and Africa Steroid APIs Sales YoY (2021-2032) & (tons) Figure 26. Global Steroid APIs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Steroid APIs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Steroid APIs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Steroid APIs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Steroid APIs Revenue Market Share by Type (2021-2032) Figure 32. Global Steroid APIs Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 33. Global Steroid APIs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Steroid APIs Sales Market Share by Type (2021-2032) Figure 35. Global Steroid APIs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Steroid APIs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Steroid APIs Revenue Market Share by Application (2021-2032) Figure 38. Global Steroid APIs Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 39. Global Steroid APIs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Steroid APIs Sales Market Share by Application (2021-2032) Figure 41. North America Steroid APIs Revenue Share by Type (2021-2032) Figure 42. North America Steroid APIs Sales Share by Type (2021-2032) Figure 43. North America Steroid APIs Revenue Share by Application (2021-2032) Figure 44. North America Steroid APIs Sales Share by Application (2021-2032) Figure 45. North America Steroid APIs Revenue Share by Country (2021-2032) Figure 46. North America Steroid APIs Sales Share by Country (2021-2032) Figure 47. Europe Steroid APIs Revenue Share by Type (2021-2032) Figure 48. Europe Steroid APIs Sales Share by Type (2021-2032) Figure 49. Europe Steroid APIs Revenue Share by Application (2021-2032) Figure 50. Europe Steroid APIs Sales Share by Application (2021-2032) Figure 51. Europe Steroid APIs Revenue Share by Country (2021-2032) Figure 52. Europe Steroid APIs Sales Share by Country (2021-2032) Figure 53. China Steroid APIs Revenue Share by Type (2021-2032) Figure 54. China Steroid APIs Sales Share by Type (2021-2032) Figure 55. China Steroid APIs Revenue Share by Application (2021-2032) Figure 56. China Steroid APIs Sales Share by Application (2021-2032) Figure 57. Asia Steroid APIs Revenue Share by Type (2021-2032) Figure 58. Asia Steroid APIs Sales Share by Type (2021-2032) Figure 59. Asia Steroid APIs Revenue Share by Application (2021-2032) Figure 60. Asia Steroid APIs Sales Share by Application (2021-2032) Figure 61. Asia Steroid APIs Revenue Share by Country (2021-2032) Figure 62. Asia Steroid APIs Sales Share by Country (2021-2032) Figure 63. SAMEA Steroid APIs Revenue Share by Type (2021-2032) Figure 64. SAMEA Steroid APIs Sales Share by Type (2021-2032) Figure 65. SAMEA Steroid APIs Revenue Share by Application (2021-2032) Figure 66. SAMEA Steroid APIs Sales Share by Application (2021-2032) Figure 67. SAMEA Steroid APIs Revenue Share by Country (2021-2032) Figure 68. SAMEA Steroid APIs Sales Share by Country (2021-2032) Figure 69. Steroid APIs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Steroid APIs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Estrogens
  • Anabolics
  • Corticosteroids
  • Progestinics
  • Others
Applications
  • Industrial
  • Laboratory
Companies covered
  • Zhejiang Xianju Pharmaceutical
  • Tianjin Tianyao Pharmaceutical
  • Sanofi
  • MSD
  • Tianjin Jinjin Pharmaceutical
  • Pfizer
  • Henan LIHUA Pharmaceutical
  • Bayer
  • Steroid

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Steroid APIs Market by Type
  3. 1.2.1 Global Steroid APIs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Estrogens
  5. 1.2.3 Anabolics
  6. 1.2.4 Corticosteroids
  7. 1.2.5 Progestinics
  8. 1.2.6 Others
  9. 1.3 Steroid APIs Market by Application
  10. 1.3.1 Global Steroid APIs Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Industrial
  12. 1.3.3 Laboratory
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Steroid APIs Market Dynamics
  1. 2.1 Steroid APIs Industry Trends
  2. 2.2 Steroid APIs Industry Drivers
  3. 2.3 Steroid APIs Industry Opportunities and Challenges
  4. 2.4 Steroid APIs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Steroid APIs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Steroid APIs Revenue by Region
  3. 3.2.1 Global Steroid APIs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Steroid APIs Revenue by Region (2021-2026)
  5. 3.2.3 Global Steroid APIs Revenue by Region (2027-2032)
  6. 3.2.4 Global Steroid APIs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Steroid APIs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Steroid APIs Sales by Region
  9. 3.4.1 Global Steroid APIs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Steroid APIs Sales by Region (2021-2026)
  11. 3.4.3 Global Steroid APIs Sales by Region (2027-2032)
  12. 3.4.4 Global Steroid APIs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Steroid APIs Revenue by Manufacturers
  2. 4.1.1 Global Steroid APIs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Steroid APIs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Steroid APIs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Steroid APIs Sales by Manufacturers
  6. 4.2.1 Global Steroid APIs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Steroid APIs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Steroid APIs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Steroid APIs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Steroid APIs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Steroid APIs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Steroid APIs Manufacturers, Product Type & Application
  13. 4.7 Global Steroid APIs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Steroid APIs Market CR5 and HHI
  16. 4.8.2 2025 Steroid APIs Tier 1, Tier 2, and Tier 3
5 Steroid APIs Market by Type
  1. 5.1 Global Steroid APIs Revenue by Type
  2. 5.1.1 Global Steroid APIs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Steroid APIs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Steroid APIs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Steroid APIs Sales by Type
  6. 5.2.1 Global Steroid APIs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Steroid APIs Sales by Type (2021-2032) & (tons)
  8. 5.2.3 Global Steroid APIs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Steroid APIs Price by Type
6 Steroid APIs Market by Application
  1. 6.1 Global Steroid APIs Revenue by Application
  2. 6.1.1 Global Steroid APIs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Steroid APIs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Steroid APIs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Steroid APIs Sales by Application
  6. 6.2.1 Global Steroid APIs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Steroid APIs Sales by Application (2021-2032) & (tons)
  8. 6.2.3 Global Steroid APIs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Steroid APIs Price by Application
7 Company Profiles
  1. 7.1 Zhejiang Xianju Pharmaceutical
  2. 7.1.1 Zhejiang Xianju Pharmaceutical Company Information
  3. 7.1.2 Zhejiang Xianju Pharmaceutical Business Overview
  4. 7.1.3 Zhejiang Xianju Pharmaceutical Steroid APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zhejiang Xianju Pharmaceutical Steroid APIs Product Portfolio
  6. 7.1.5 Zhejiang Xianju Pharmaceutical Recent Developments
  7. 7.2 Tianjin Tianyao Pharmaceutical
  8. 7.2.1 Tianjin Tianyao Pharmaceutical Company Information
  9. 7.2.2 Tianjin Tianyao Pharmaceutical Business Overview
  10. 7.2.3 Tianjin Tianyao Pharmaceutical Steroid APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Tianjin Tianyao Pharmaceutical Steroid APIs Product Portfolio
  12. 7.2.5 Tianjin Tianyao Pharmaceutical Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Steroid APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Steroid APIs Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 MSD
  20. 7.4.1 MSD Company Information
  21. 7.4.2 MSD Business Overview
  22. 7.4.3 MSD Steroid APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 MSD Steroid APIs Product Portfolio
  24. 7.4.5 MSD Recent Developments
  25. 7.5 Tianjin Jinjin Pharmaceutical
  26. 7.5.1 Tianjin Jinjin Pharmaceutical Company Information
  27. 7.5.2 Tianjin Jinjin Pharmaceutical Business Overview
  28. 7.5.3 Tianjin Jinjin Pharmaceutical Steroid APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Tianjin Jinjin Pharmaceutical Steroid APIs Product Portfolio
  30. 7.5.5 Tianjin Jinjin Pharmaceutical Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Steroid APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Steroid APIs Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 Henan LIHUA Pharmaceutical
  38. 7.7.1 Henan LIHUA Pharmaceutical Company Information
  39. 7.7.2 Henan LIHUA Pharmaceutical Business Overview
  40. 7.7.3 Henan LIHUA Pharmaceutical Steroid APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Henan LIHUA Pharmaceutical Steroid APIs Product Portfolio
  42. 7.7.5 Henan LIHUA Pharmaceutical Recent Developments
  43. 7.8 Bayer
  44. 7.8.1 Bayer Company Information
  45. 7.8.2 Bayer Business Overview
  46. 7.8.3 Bayer Steroid APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Bayer Steroid APIs Product Portfolio
  48. 7.8.5 Bayer Recent Developments
  49. 7.9 Steroid
  50. 7.9.1 Steroid Company Information
  51. 7.9.2 Steroid Business Overview
  52. 7.9.3 Steroid Steroid APIs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Steroid Steroid APIs Product Portfolio
  54. 7.9.5 Steroid Recent Developments
8 North America
  1. 8.1 North America Steroid APIs Market Size by Type
  2. 8.1.1 North America Steroid APIs Revenue by Type (2021-2032)
  3. 8.1.2 North America Steroid APIs Sales by Type (2021-2032)
  4. 8.1.3 North America Steroid APIs Price by Type (2021-2032)
  5. 8.2 North America Steroid APIs Market Size by Application
  6. 8.2.1 North America Steroid APIs Revenue by Application (2021-2032)
  7. 8.2.2 North America Steroid APIs Sales by Application (2021-2032)
  8. 8.2.3 North America Steroid APIs Price by Application (2021-2032)
  9. 8.3 North America Steroid APIs Market Size by Country
  10. 8.3.1 North America Steroid APIs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Steroid APIs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Steroid APIs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Steroid APIs Market Size by Type
  2. 9.1.1 Europe Steroid APIs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Steroid APIs Sales by Type (2021-2032)
  4. 9.1.3 Europe Steroid APIs Price by Type (2021-2032)
  5. 9.2 Europe Steroid APIs Market Size by Application
  6. 9.2.1 Europe Steroid APIs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Steroid APIs Sales by Application (2021-2032)
  8. 9.2.3 Europe Steroid APIs Price by Application (2021-2032)
  9. 9.3 Europe Steroid APIs Market Size by Country
  10. 9.3.1 Europe Steroid APIs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Steroid APIs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Steroid APIs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Steroid APIs Market Size by Type
  2. 10.1.1 China Steroid APIs Revenue by Type (2021-2032)
  3. 10.1.2 China Steroid APIs Sales by Type (2021-2032)
  4. 10.1.3 China Steroid APIs Price by Type (2021-2032)
  5. 10.2 China Steroid APIs Market Size by Application
  6. 10.2.1 China Steroid APIs Revenue by Application (2021-2032)
  7. 10.2.2 China Steroid APIs Sales by Application (2021-2032)
  8. 10.2.3 China Steroid APIs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Steroid APIs Market Size by Type
  2. 11.1.1 Asia Steroid APIs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Steroid APIs Sales by Type (2021-2032)
  4. 11.1.3 Asia Steroid APIs Price by Type (2021-2032)
  5. 11.2 Asia Steroid APIs Market Size by Application
  6. 11.2.1 Asia Steroid APIs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Steroid APIs Sales by Application (2021-2032)
  8. 11.2.3 Asia Steroid APIs Price by Application (2021-2032)
  9. 11.3 Asia Steroid APIs Market Size by Country
  10. 11.3.1 Asia Steroid APIs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Steroid APIs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Steroid APIs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Steroid APIs Market Size by Type
  2. 12.1.1 SAMEA Steroid APIs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Steroid APIs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Steroid APIs Price by Type (2021-2032)
  5. 12.2 SAMEA Steroid APIs Market Size by Application
  6. 12.2.1 SAMEA Steroid APIs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Steroid APIs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Steroid APIs Price by Application (2021-2032)
  9. 12.3 SAMEA Steroid APIs Market Size by Country
  10. 12.3.1 SAMEA Steroid APIs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Steroid APIs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Steroid APIs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Steroid APIs Value Chain Analysis
  2. 13.1.1 Steroid APIs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Steroid APIs Production Mode & Process
  6. 13.2 Steroid APIs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Steroid APIs Distributors
  9. 13.2.3 Steroid APIs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst